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Abstract In Alagille syndrome, routine follow-up imaging
of the liver plays an important role in detecting early
parenchymal changes and to evaluate portal hypertension.
Modern contrast-enhanced imaging methods not only allow
early detection of focal liver lesions, but also enable further
characterization of their nature and guide biopsy proce-
dures. We present the US and MR imaging findings of
hepatocellular carcinoma and a regenerating nodule in a
3-year-old child with Alagille syndrome.
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Introduction
Alagille syndrome is a rare, congenital disease with a
prevalence of 1:70,000 births that is associated with a
microdeletion of the short arm of chromosome 20 [1].
Infants present in the first days of life with jaundice as a
result of chronic intrahepatic cholestasis due to paucity and
hypoplasia of the intralobular bile ducts [1]. Malformations
of the face, heart, skeleton and kidneys are related [1]. The
initial evaluation of the child includes a clinical examination,
laboratory tests and imaging of the liver. Liver biopsy and
molecular genetic work-up finally establishes the diagnosis of
Alagille syndrome.
Intrahepatic cholestasis causes biliary cirrhosis and the
only curative treatment remains liver transplantation. Few
cases of associated hepatic nodular lesions such as
hepatocellular carcinoma (HCC) or hepatic nodular hyper-
plasia (HNH) have been reported [2–4].
We describe the US and MR imaging findings of the
liver in a 3-year-old child with Alagille syndrome and
histological confirmed HCC and regenerating nodule.
Case report
At 13 weeks old, our patient was admitted to the
gastroenterology clinic because of jaundice. Alagille syn-
drome was diagnosed due to the findings of persistent
jaundice, peripheral pulmonary artery stenosis, typical
facies and butterfly vertebrae (Fig. 1). The diagnosis was
established with a de novo mutation of the protein-encoding
JAG1-region of chromosome 20.
In addition to clinical follow-up, liver US was performed
every 6 months. At the age of 10 months the child
developed biliary cirrhosis with hepato-splenomegaly,
portal hypertension and oesophageal varices grade I. At
the age of 36 months nodular changes of the liver
parenchyma were noted. There was a hypoechoic, 2.7-cm
well-defined liver lesion in segment VI/VII and another
large, isoechoic nodular lesion in segment V displacing the
adjacent vessels (Fig. 2).
Since there were new focal liver lesions with different
sonographic echotextures and elevated alpha fetoprotein
(AFP) levels, these lesions were further characterized with a
standard paediatric MRI-liver protocol and dynamic
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contrast-enhanced sequences with gadolinium using a 1.5-T
magnet (Figs. 3 and 4).
The liver lesion in segment VI/VII showed slight hyperin-
tense signal on the T2-W sequence and hypointense signal on
the T1-W sequence. The lesion was characterized by early
enhancement in the arterial phase and a wash-out phenome-
non in the late phases on the dynamic contrast-enhanced
images. This enhancement pattern was consistent with a
malignant lesion, most likely a HCC. The larger liver lesion in
segment V had similar intensity to liver parenchyma on all
sequences and the T1-W dynamic contrast-enhanced images
showed isointense signal in all phases with central hypo-
intense signal and a prominent central vessel. This enhance-
ment pattern was consistent with a HNH. A biopsy of the
likely malignant lesion confirmed a moderately differentiated
HCC.
As the only curative option, orthotopic liver transplan-
tation was performed and histological investigation of the
liver confirmed the diagnosis of HCC of the smaller lesion
and regenerating nodule of the larger lesion.
Discussion
There are only a few reported cases in the literature of
associated liver tumours (HCC and HNH) in Alagille
syndrome and the youngest child described is a 17-month-
old boy [2–5].
US is the imaging method of choice for the first
evaluation and routine follow-up examination of the liver
in children. An inhomogeneous and echogenic liver paren-
chyma may be seen due to steatosis, fibrosis and/or cirrhosis
of the liver. Blane et al. [6] described that liver lesions in
children cannot be characterized using US alone and further
imaging methods must be performed. Dynamic contrast-
enhanced US (CEUS) imaging of focal liver lesions is a
promising technique, but still not approved for children.
Fig. 2 US of the liver at 36 months of age. A new 2.7-cm hypoechoic
liver lesion (arrow) and a large isoechoic liver lesion (asterisk) are
detected
Fig. 1 Chest radiograph at 13 weeks of age with a normal
cardiothymic silhouette. Butterfly vertebrae of the lower thoracic
spine are noted (arrow)
Fig. 3 MRI of the liver at
36 months of age. a Axial T2-W
and (b) axial T1-W sequences of
the liver. The liver lesion in
segment VI/VII (arrow) shows
slight hyperintense signal in the
T2-W image and hypointense
signal in the T1-W image.
The larger lesion in segment V
(asterisk) has almost similar in-
tensity to the liver parenchyma in
both sequences. A prominent
central vessel is noted
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Contrast-enhanced dynamic techniques are used to
differentiate among vascular lesions, HNH or malignant
lesions demonstrating a characteristic enhancement pattern
(reported sensitivity of HCC >1 cm with dynamic contrast
imaging is up to 87% with a specificity of 79% [7]. For
benign liver lesions the accuracy is 83.1% [8].)
MRI and US are both methods without ionizing radiation
and with good soft-tissue contrast. The advantage of MRI is
a significantly better overview of the liver and the detection
of several lesions at the same time, while in CEUS only
part of the liver per administration of contrast medium may
be continuously imaged. On the other hand, there is usually
no need for sedation or anaesthesia when performing
CEUS.
The MRI findings in our case showed a different
contrast-enhancement pattern between the malignant (early
enhancement and wash-out) and the benign liver lesion.
The regenerating nodule showed an isointense enhancement
pattern, a central hypointense scar and a prominent central
vessel that has been described in the literature to be
consistent with HNH [5].
In summary, Alagille syndrome is a rare disease resulting
in cirrhosis of the liver in children. Complications include
focal liver lesions such as HCC and US follow-up studies
are mandatory to detect them as early as possible. Contrast-
enhanced dynamic imaging of the liver is recommended to
characterize these lesions and plays an important role for
further management.
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Fig. 4 MRI of the liver at 36 months of age. T1-W dynamic contrast-
enhanced sequences with gadolinium. The lesion in segment VI/VII
(arrow) shows hypointense signal without contrast agent (a), early
enhancement in the arterial phase (b) and a wash-out phenomenon in
the late phases (c and d). The larger liver lesion in segment V
(asterisk) shows almost isointense signal in all phases and a central
hypointense signal. The prominent vessel is best visible in the arterial
phase (b)
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